| Trial ID: | L0104 |
| Source ID: | NCT02265276
|
| Associated Drug: |
Saroglitazar
|
| Title: |
A Prospective, Randomized Trial to Compare saroGLitazar With pioglitAZone in Nonalcoholic Fatty livEr Disease
|
| Acronym: |
GLAZED
|
| Status: |
Unknown status
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Fatty Liver
|
| Interventions: |
Drug: Saroglitazar|Drug: Pioglitazone
|
| Outcome Measures: |
Change in the NAFLD fibrosis score|Change in body composition|Change in insulin resistance|Change in lipid profile|Change in HbA1c
|
| Sponsor/Collaborators: |
Command Hospital, India
|
| Gender: |
All
|
| Age: |
18 Years to 70 Years ?? (Adult, Older Adult)
|
| Phases: |
Phase 3
|
| Enrollment: |
100
|
| Study Type: |
Interventional
|
| Study Designs: |
Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment
|
| Start Date: |
October 2014
|
| Completion Date: |
September 2015
|
| Results First Posted: |
--
|
| Last Update Posted: |
October 16, 2014
|
| Locations: |
Command Hospital, Panchkula, Haryana, India
|
| URL: |
https://ClinicalTrials.gov/show/NCT02265276
|
